Global Immunoglobulin (Ig) Market 2022-2028

November 2022 | 75 pages | ID: G81DBC26E3D7EN
Gen Consulting Company

Abstracts

Immunoglobulin or Ig, also known as gamma globulin or immune globulin, refers to the liquid plasma component of blood that contains immunoglobulins or antibodies. They are glycoprotein molecules produced by plasma cells (white blood cells). Immunoglobulins act as a critical part of the immune response by specifically recognizing and binding to particular antigens, such as bacteria or viruses, and aiding in their destruction. The global immunoglobulin market is projected to rise by USD 5.9 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 6.1 percent during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global immunoglobulin market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the immunoglobulin industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, mode of delivery, application, end user, and region. The global market for immunoglobulin can be segmented by product: IgA, IgD, IgE, IgG, IgM. The IgG segment held the largest share of the global immunoglobulin market in 2021 and is anticipated to hold its share during the forecast period. Immunoglobulin market is further segmented by mode of delivery: intravenous immunoglobulins, intramuscular immunoglobulins, subcutaneous immunoglobulins. Globally, the intravenous immunoglobulins segment made up the largest share of the immunoglobulin market. Based on application, the immunoglobulin market is segmented into: hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency disorder, myasthenia gravis, others. The Immunodeficiency disorder segment was the largest contributor to the global immunoglobulin market in 2021. On the basis of end user, the immunoglobulin market also can be divided into: homecare, hospitals & clinics. Immunoglobulin market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

By product:

• IgA
• IgD
• IgE
• IgG
• IgM

By mode of delivery:

• intravenous immunoglobulins
• intramuscular immunoglobulins
• subcutaneous immunoglobulins

By application:

• hypogammaglobulinemia
• chronic inflammatory demyelinating polyneuropathy (CIDP)
• Immunodeficiency disorder
• myasthenia gravis
• others

By end user:

• homecare
• hospitals & clinics

By region:

• North America
• Europe
• Asia-Pacific
• MEA (Middle East and Africa)
• Latin America

The global immunoglobulin market report offers detailed information on several market vendors, including ADMA Biologics Inc., Bharat Serums And Vaccines Limited (BSV), Biotest AG, China Biologic Products, Inc. (Shandong Taibang Biological Products Co., Ltd.), CSL Limited, Grifols, S.A., Johnson & Johnson, Kedrion Biopharma Inc. (Kedrion SpA), LFB S.A., Octapharma AG, Shanghai RAAS Blood Products Co., Ltd., Takeda Pharmaceutical Company Limited, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global immunoglobulin market.
• To classify and forecast the global immunoglobulin market based on product, mode of delivery, application, end user, region.
• To identify drivers and challenges for the global immunoglobulin market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global immunoglobulin market.
• To identify and analyze the profile of leading players operating in the global immunoglobulin market.

Why Choose This Report

• Gain a reliable outlook of the global immunoglobulin market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

IgA
IgD
IgE
IgG
IgM

PART 6. MARKET BREAKDOWN BY MODE OF DELIVERY

Intravenous immunoglobulins
Intramuscular immunoglobulins
Subcutaneous immunoglobulins

PART 7. MARKET BREAKDOWN BY APPLICATION

Hypogammaglobulinemia
Chronic inflammatory demyelinating polyneuropathy (CIDP)
Immunodeficiency disorder
Myasthenia gravis
Others

PART 8. MARKET BREAKDOWN BY END USER

Homecare
Hospitals & clinics

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

ADMA Biologics Inc.
Bharat Serums And Vaccines Limited (BSV)
Biotest AG
China Biologic Products, Inc. (Shandong Taibang Biological Products Co., Ltd.)
CSL Limited
Grifols, S.A.
Johnson & Johnson
Kedrion Biopharma Inc. (Kedrion SpA)
LFB S.A.
Octapharma AG
Shanghai RAAS Blood Products Co., Ltd.
Takeda Pharmaceutical Company Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER